Oramed Pharmaceuticals Inc. (TLV: ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA
877.00
-9.50 (-1.07%)
Dec 22, 2024, 3:49 PM IDT
Oramed Pharmaceuticals Revenue
In the year 2023, Oramed Pharmaceuticals had annual revenue of $1.34M USD, down -50.43%.
Revenue
$1.34M
Revenue Growth
-50.43%
P/S Ratio
n/a
Revenue / Employee
$335.00K
Employees
4
Market Cap
348.36M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.34M | -1.36M | -50.43% |
Dec 31, 2022 | 2.70M | -9.00K | -0.33% |
Dec 31, 2021 | 2.71M | 9.00K | 0.33% |
Aug 31, 2021 | 2.70M | -9.00K | -0.33% |
Dec 31, 2020 | 2.71M | 2.00K | 0.07% |
Aug 31, 2020 | Pro | Pro | Pro |
Aug 31, 2019 | Pro | Pro | Pro |
Aug 31, 2018 | Pro | Pro | Pro |
Aug 31, 2017 | Pro | Pro | Pro |
Aug 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOramed Pharmaceuticals News
- 2 months ago - Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt - PRNewsWire
- 6 months ago - Oramed Letter to Shareholders - PRNewsWire
- 6 months ago - Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock - PRNewsWire
- 1 year ago - Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company - PRNewsWire
- 1 year ago - Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally - PRNewsWire
- 1 year ago - Oramed to Present at the 83rd American Diabetes Association Conference - PRNewsWire
- 1 year ago - Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit - PRNewsWire
- 1 year ago - Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China - PRNewsWire